跳转至内容
Merck

900743

Sigma-Aldrich

支化PEI-g-PEG

PEG Mn 5,000

别名:

PEI-g-PEG, PEI-PEG, 支链聚乙烯亚胺-接枝- 聚(乙二醇)

登录查看公司和协议定价


About This Item

线性分子式:
H3CO(CH2CH2O)nC10H18N2O3(NHCH2CH2)mNH2
分類程式碼代碼:
12162002
NACRES:
NA.23

形狀

liquid

品質等級

分子量

PEG Mn 5,000

儲存溫度

2-8°C

應用

支化 PEI-g-PEG,PEG Mn 5000 衍生自 Sigma-Aldrich 产品 408727。基于支化 PEI 的近似分子量为 25,000,产物 900926 每 PEI 单元含有约 15 个接枝 PEG 链(通过 NMR)。

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Katharina Ladewig et al.
Journal of biomedical materials research. Part A, 102(7), 2137-2146 (2013-07-31)
High molecular weight (MW) polyethyleneimine (PEI) has been successfully used for the transfection of a broad variety of cell lines. In contrast to low MW PEI, which exhibits low transfection efficiencies but also low cytotoxicity, high MW PEI-mediated transfection achieves
Chunxi Liu et al.
Biomaterials, 34(10), 2547-2564 (2013-01-22)
Co-delivery of nucleic acids and chemotherapeutics has a potential to efficaciously treat human diseases via their synergetic effects. Activable therapeutic tools at the nanoscale are suitable platforms for combination therapy. In this study, we have developed a multifunctional nanoscaled delivery
Jing Wang et al.
Biomaterials science, 4(9), 1351-1360 (2016-07-19)
Zwitterionic poly(carboxybetaine) (PCB), poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC) and non-ionic poly(ethylene glycol) (PEG), which have similar degrees of polymerization, were grafted to branched polyethyleneimine (PEI) to generate PCB-grafted PEI (PEI-PCB), PMPC-grafted PEI (PEI-PMPC) and PEG-grafted PEI (PEI-PEG) copolymers, respectively. These grafted PEI

商品

Professor Yoshiki Katayama (Kyushu University, Japan) discusses recent advances in drug delivery systems and strategies that exploit the EPR effect, with a special focus on stimuli-responsive systems based on novel materials.

CRISPR/Cas9 delivery via nonviral nanoparticles shows promising advancements for gene editing in disease treatment.

CRISPR/Cas9 delivery via nonviral nanoparticles shows promising advancements for gene editing in disease treatment.

CRISPR/Cas9 delivery via nonviral nanoparticles shows promising advancements for gene editing in disease treatment.

查看所有结果

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门